Hello guys, Welcome to Africa's Largest Video Search Engine, and you are watching The use of targeted drug therapy for aggressive lymphoma. and this video is uploaded by VJHemOnc – Video Journal of Hematology & HemOnc at 2024-07-05T04:46:44-07:00. We are just promoting this video only for entertainment and educational purpose only. I hop you like our Video Search Engine. [-dOdLO6XiQY]
| Name | The use of targeted drug therapy for aggressive lymphoma |
| Video Uploader | Video From VJHemOnc – Video Journal of Hematology & HemOnc |
| Upload Date | This Video Uploaded At 05-07-2024 11:46:44 |
| Video Discription | Mariana Bastos, MD, PhD, Gregorio Marañón University General Hospital, Madrid, Spain, discusses advancements in targeted therapies for aggressive lymphoma. She highlights early-line treatments combining novel cereblon E3 ligase modulators (CELMoDs) or atezolizumab with the R-CHOP regimen. In the relapsed/refractory (R/R) setting, she notes the combinations of glofitamab with a novel CD19/4-1BB T-cell engager and epcoritamab with polatuzumab vedotin-R-CHP (pola-R-CHP). This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved. [-dOdLO6XiQY] |
| Category | Education |
| Tags | Speaker: Mariana Bastos | Institution: Gregorio Marañón University General Hospital | Event: EHA 2024 | Format: Interview | Subject: Lymphoma | Subject: Non-Hodgkin Lymphoma | Subject: Aggressive & Diffuse Large B-Cell Lymphoma | Field: Treatment | Field: Immuno-Oncology | Medicines: Antibodies | Medicines: Glofitamab | Medicines: Epcoritamab | Medicines: Atezolizumab | Medicines: R-CHOP | Medicines: R-CHP | CELMoDs | targeted therapy | combination therapy | R/R aggressive lymphoma | pola-R-CHP |
